APO Research
Talk to an analyst

APO RESEARCH · REPORT

Viral Vector Purification Media

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Viral Vector Purification Media Market Outlook and Growth Opportunities 2026

13 August 2026191 pages

Choose your research edition.

Industry ResearchViral Vector Purification Media Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Viral Vector Purification Media Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Viral Vector Purification Media Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Viral Vector Purification Media Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Viral Vector Purification Media Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Viral Vector Purification Media market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Viral Vector Purification Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Viral Vector Purification Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Viral Vector Purification Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Viral Vector Purification Media market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Viral Vector Purification Media market include Cytiva, Thermo Fisher Scientific, Repligen, Sartorius, Bio-Rad, Merck, Tosoh Bioscience, Astrea Bioseparations and JNC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Viral Vector Purification Media market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Viral Vector Purification Media and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Viral Vector Purification Media sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Viral Vector Purification Media market size, projected growth trends, production technologies, key applications, and end-use industries.

Viral Vector Purification Media Segment by Company

Cytiva

Thermo Fisher Scientific

Repligen

Sartorius

Bio-Rad

Merck

Tosoh Bioscience

Astrea Bioseparations

JNC

Sepax Technologies

Sunresin

Bestchrom

NanoMicro

BioToolomics

Viral Vector Purification Media Segment by Type

AAV Affinity Media

Anion Exchange Media

Cation Exchange Media

Mixed-Mode Media

Core-Bead Flow-Through Media

Monolith and Membrane Adsorbers

Viral Vector Purification Media Segment by Application

AAV Gene Therapy Vector Production

Lentiviral Vector Production

Adenoviral Vector and Vaccine Production

Oncolytic Virus and VLP Production

Process Development and Scale-Up

QC and Analytical Sample Preparation

Viral Vector Purification Media Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Viral Vector Purification Media status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Viral Vector Purification Media market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Viral Vector Purification Media significant trends, drivers, influence factors in global and regions.

6. To analyze Viral Vector Purification Media competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Viral Vector Purification Media market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Viral Vector Purification Media and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Viral Vector Purification Media.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Viral Vector Purification Media market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Viral Vector Purification Media industry.

Chapter 3: Detailed analysis of Viral Vector Purification Media manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Viral Vector Purification Media in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Viral Vector Purification Media in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Viral Vector Purification Media Industry Trends Table 2. Viral Vector Purification Media Industry Drivers Table 3. Viral Vector Purification Media Industry Opportunities and Challenges Table 4. Viral Vector Purification Media Industry Restraints Table 5. Global Viral Vector Purification Media Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Viral Vector Purification Media Revenue Share by Company (2021-2026) Table 7. Global Viral Vector Purification Media Sales Volume by Company (t) & (2021-2026) Table 8. Global Viral Vector Purification Media Sales Volume Share by Company (2021-2026) Table 9. Global Viral Vector Purification Media Average Price (USD/t) of Company (2021-2026) Table 10. Global Viral Vector Purification Media Company Ranking, (2024-2026) & (USD Million) Table 11. Global Viral Vector Purification Media Key Company Manufacturing Base & Headquarters Table 12. Global Viral Vector Purification Media Company, Product Type & Application Table 13. Global Viral Vector Purification Media Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Viral Vector Purification Media by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of AAV Affinity Media Table 18. Significant Companies of Anion Exchange Media Table 19. Significant Companies of Cation Exchange Media Table 20. Significant Companies of Mixed-Mode Media Table 21. Significant Companies of Core-Bead Flow-Through Media Table 22. Significant Companies of Monolith and Membrane Adsorbers Table 23. Global Viral Vector Purification Media Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 24. Global Viral Vector Purification Media Sales Volume by Type (2021-2026) & (t) Table 25. Global Viral Vector Purification Media Sales Volume by Type (2027-2032) & (t) Table 26. Global Viral Vector Purification Media Sales Volume Share by Type (2021-2026) Table 27. Global Viral Vector Purification Media Sales Volume Share by Type (2027-2032) Table 28. Global Viral Vector Purification Media Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Viral Vector Purification Media Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Viral Vector Purification Media Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Viral Vector Purification Media Sales Value Share by Type (2021-2026) Table 32. Global Viral Vector Purification Media Sales Value Share by Type (2027-2032) Table 33. Significant Companies of AAV Gene Therapy Vector Production Table 34. Significant Companies of Lentiviral Vector Production Table 35. Significant Companies of Adenoviral Vector and Vaccine Production Table 36. Significant Companies of Oncolytic Virus and VLP Production Table 37. Significant Companies of Process Development and Scale-Up Table 38. Significant Companies of QC and Analytical Sample Preparation Table 39. Global Viral Vector Purification Media Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 40. Global Viral Vector Purification Media Sales Volume by Application (2021-2026) & (t) Table 41. Global Viral Vector Purification Media Sales Volume by Application (2027-2032) & (t) Table 42. Global Viral Vector Purification Media Sales Volume Share by Application (2021-2026) Table 43. Global Viral Vector Purification Media Sales Volume Share by Application (2027-2032) Table 44. Global Viral Vector Purification Media Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Viral Vector Purification Media Sales Value by Application (2021-2026) & (US$ Million) Table 46. Global Viral Vector Purification Media Sales Value by Application (2027-2032) & (US$ Million) Table 47. Global Viral Vector Purification Media Sales Value Share by Application (2021-2026) Table 48. Global Viral Vector Purification Media Sales Value Share by Application (2027-2032) Table 49. Global Viral Vector Purification Media Sales by Region: 2021 VS 2025 VS 2032 (t) Table 50. Global Viral Vector Purification Media Sales by Region (2021-2026) & (t) Table 51. Global Viral Vector Purification Media Sales Market Share by Region (2021-2026) Table 52. Global Viral Vector Purification Media Sales by Region (2027-2032) & (t) Table 53. Global Viral Vector Purification Media Sales Market Share by Region (2027-2032) Table 54. Global Viral Vector Purification Media Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Viral Vector Purification Media Sales Value by Region (2021-2026) & (US$ Million) Table 56. Global Viral Vector Purification Media Sales Value Share by Region (2021-2026) Table 57. Global Viral Vector Purification Media Sales Value by Region (2027-2032) & (US$ Million) Table 58. Global Viral Vector Purification Media Sales Value Share by Region (2027-2032) Table 59. Global Viral Vector Purification Media Market Average Price (USD/t) by Region (2021-2026) Table 60. Global Viral Vector Purification Media Market Average Price (USD/t) by Region (2027-2032) Table 61. Global Viral Vector Purification Media Sales by Country: 2021 VS 2025 VS 2032 (t) Table 62. Global Viral Vector Purification Media Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Viral Vector Purification Media Sales by Country (2021-2026) & (t) Table 64. Global Viral Vector Purification Media Sales Market Share by Country (2021-2026) Table 65. Global Viral Vector Purification Media Sales by Country (2027-2032) & (t) Table 66. Global Viral Vector Purification Media Sales Market Share by Country (2027-2032) Table 67. Global Viral Vector Purification Media Sales Value by Country (2021-2026) & (US$ Million) Table 68. Global Viral Vector Purification Media Sales Value Market Share by Country (2021-2026) Table 69. Global Viral Vector Purification Media Sales Value by Country (2027-2032) & (US$ Million) Table 70. Global Viral Vector Purification Media Sales Value Market Share by Country (2027-2032) Table 71. Cytiva Company Information Table 72. Cytiva Business Overview Table 73. Cytiva Viral Vector Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. Cytiva Viral Vector Purification Media Product Portfolio Table 75. Cytiva Recent Development Table 76. Thermo Fisher Scientific Company Information Table 77. Thermo Fisher Scientific Business Overview Table 78. Thermo Fisher Scientific Viral Vector Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. Thermo Fisher Scientific Viral Vector Purification Media Product Portfolio Table 80. Thermo Fisher Scientific Recent Development Table 81. Repligen Company Information Table 82. Repligen Business Overview Table 83. Repligen Viral Vector Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. Repligen Viral Vector Purification Media Product Portfolio Table 85. Repligen Recent Development Table 86. Sartorius Company Information Table 87. Sartorius Business Overview Table 88. Sartorius Viral Vector Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. Sartorius Viral Vector Purification Media Product Portfolio Table 90. Sartorius Recent Development Table 91. Bio-Rad Company Information Table 92. Bio-Rad Business Overview Table 93. Bio-Rad Viral Vector Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. Bio-Rad Viral Vector Purification Media Product Portfolio Table 95. Bio-Rad Recent Development Table 96. Merck Company Information Table 97. Merck Business Overview Table 98. Merck Viral Vector Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 99. Merck Viral Vector Purification Media Product Portfolio Table 100. Merck Recent Development Table 101. Tosoh Bioscience Company Information Table 102. Tosoh Bioscience Business Overview Table 103. Tosoh Bioscience Viral Vector Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 104. Tosoh Bioscience Viral Vector Purification Media Product Portfolio Table 105. Tosoh Bioscience Recent Development Table 106. Astrea Bioseparations Company Information Table 107. Astrea Bioseparations Business Overview Table 108. Astrea Bioseparations Viral Vector Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 109. Astrea Bioseparations Viral Vector Purification Media Product Portfolio Table 110. Astrea Bioseparations Recent Development Table 111. JNC Company Information Table 112. JNC Business Overview Table 113. JNC Viral Vector Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 114. JNC Viral Vector Purification Media Product Portfolio Table 115. JNC Recent Development Table 116. Sepax Technologies Company Information Table 117. Sepax Technologies Business Overview Table 118. Sepax Technologies Viral Vector Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 119. Sepax Technologies Viral Vector Purification Media Product Portfolio Table 120. Sepax Technologies Recent Development Table 121. Sunresin Company Information Table 122. Sunresin Business Overview Table 123. Sunresin Viral Vector Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 124. Sunresin Viral Vector Purification Media Product Portfolio Table 125. Sunresin Recent Development Table 126. Bestchrom Company Information Table 127. Bestchrom Business Overview Table 128. Bestchrom Viral Vector Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 129. Bestchrom Viral Vector Purification Media Product Portfolio Table 130. Bestchrom Recent Development Table 131. NanoMicro Company Information Table 132. NanoMicro Business Overview Table 133. NanoMicro Viral Vector Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 134. NanoMicro Viral Vector Purification Media Product Portfolio Table 135. NanoMicro Recent Development Table 136. BioToolomics Company Information Table 137. BioToolomics Business Overview Table 138. BioToolomics Viral Vector Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 139. BioToolomics Viral Vector Purification Media Product Portfolio Table 140. BioToolomics Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Viral Vector Purification Media Distributors List Table 144. Viral Vector Purification Media Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Viral Vector Purification Media Product Image Figure 2. Global Viral Vector Purification Media Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Viral Vector Purification Media Sales Value (2021-2032) & (US$ Million) Figure 4. Global Viral Vector Purification Media Sales (2021-2032) & (t) Figure 5. Global Viral Vector Purification Media Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Viral Vector Purification Media Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. AAV Affinity Media Image Figure 10. Anion Exchange Media Image Figure 11. Cation Exchange Media Image Figure 12. Mixed-Mode Media Image Figure 13. Core-Bead Flow-Through Media Image Figure 14. Monolith and Membrane Adsorbers Image Figure 15. Global Viral Vector Purification Media Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 16. Global Viral Vector Purification Media Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Viral Vector Purification Media Sales Volume Share by Type (2021-2032) Figure 18. Global Viral Vector Purification Media Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Viral Vector Purification Media Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Viral Vector Purification Media Sales Value Share by Type (2021-2032) Figure 21. AAV Gene Therapy Vector Production Image Figure 22. Lentiviral Vector Production Image Figure 23. Adenoviral Vector and Vaccine Production Image Figure 24. Oncolytic Virus and VLP Production Image Figure 25. Process Development and Scale-Up Image Figure 26. QC and Analytical Sample Preparation Image Figure 27. Global Viral Vector Purification Media Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 28. Global Viral Vector Purification Media Sales Volume Share 2021 VS 2025 VS 2032 Figure 29. Global Viral Vector Purification Media Sales Volume Share by Application (2021-2032) Figure 30. Global Viral Vector Purification Media Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Viral Vector Purification Media Sales Value Share 2021 VS 2025 VS 2032 Figure 32. Global Viral Vector Purification Media Sales Value Share by Application (2021-2032) Figure 33. Global Viral Vector Purification Media Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 34. Global Viral Vector Purification Media Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 35. Global Viral Vector Purification Media Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 36. Global Viral Vector Purification Media Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 37. North America Viral Vector Purification Media Sales Value (2021-2032) & (US$ Million) Figure 38. North America Viral Vector Purification Media Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Europe Viral Vector Purification Media Sales Value (2021-2032) & (US$ Million) Figure 40. Europe Viral Vector Purification Media Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Asia-Pacific Viral Vector Purification Media Sales Value (2021-2032) & (US$ Million) Figure 42. Asia-Pacific Viral Vector Purification Media Sales Value Share by Country (%), 2025 VS 2032 Figure 43. South America Viral Vector Purification Media Sales Value (2021-2032) & (US$ Million) Figure 44. South America Viral Vector Purification Media Sales Value Share by Country (%), 2025 VS 2032 Figure 45. Middle East & Africa Viral Vector Purification Media Sales Value (2021-2032) & (US$ Million) Figure 46. Middle East & Africa Viral Vector Purification Media Sales Value Share by Country (%), 2025 VS 2032 Figure 47. USA Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. USA Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. USA Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Canada Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Canada Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Canada Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Mexico Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Mexico Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Mexico Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Germany Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Germany Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Germany Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. France Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. France Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. France Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. U.K. Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. U.K. Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. U.K. Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Italy Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Italy Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Italy Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Spain Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Spain Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Spain Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Russia Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Russia Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Russia Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Netherlands Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Netherlands Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Netherlands Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Nordic Countries Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Nordic Countries Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Nordic Countries Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. China Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. China Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. China Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Japan Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Japan Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Japan Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. South Korea Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. South Korea Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. South Korea Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. India Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. India Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. India Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Australia Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Australia Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Australia Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Southeast Asia Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Southeast Asia Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Southeast Asia Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Brazil Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Brazil Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Brazil Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Argentina Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Argentina Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Argentina Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Chile Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Chile Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Chile Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Colombia Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Colombia Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Colombia Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Peru Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Peru Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Peru Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Saudi Arabia Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Saudi Arabia Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Israel Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Israel Arabia Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Israel Arabia Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. UAE Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. UAE Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. UAE Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Turkey Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Turkey Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Turkey Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Iran Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Iran Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Iran Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Egypt Viral Vector Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 129. Egypt Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 130. Egypt Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 131. Viral Vector Purification Media Value Chain Figure 132. Manufacturing Cost Structure Figure 133. Viral Vector Purification Media Sales Mode & Process Figure 134. Direct Comparison with Distribution Share Figure 135. Distributors Profiles Figure 136. Years Considered Figure 137. Research Process Figure 138. Key Executives Interviewed

Scope & coverage.

Types
  • AAV Affinity Media
  • Anion Exchange Media
  • Cation Exchange Media
  • Mixed-Mode Media
  • Core-Bead Flow-Through Media
  • Monolith and Membrane Adsorbers
Applications
  • AAV Gene Therapy Vector Production
  • Lentiviral Vector Production
  • Adenoviral Vector and Vaccine Production
  • Oncolytic Virus and VLP Production
  • Process Development and Scale-Up
  • QC and Analytical Sample Preparation
Companies covered
  • Cytiva
  • Thermo Fisher Scientific
  • Repligen
  • Sartorius
  • Bio-Rad
  • Merck
  • Tosoh Bioscience
  • Astrea Bioseparations
  • JNC
  • Sepax Technologies
  • Sunresin
  • Bestchrom
  • NanoMicro
  • BioToolomics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Viral Vector Purification Media Sales Value (2021-2032)
  4. 1.2.2 Global Viral Vector Purification Media Sales Volume (2021-2032)
  5. 1.2.3 Global Viral Vector Purification Media Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Viral Vector Purification Media Market Dynamics
  1. 2.1 Viral Vector Purification Media Industry Trends
  2. 2.2 Viral Vector Purification Media Industry Drivers
  3. 2.3 Viral Vector Purification Media Industry Opportunities and Challenges
  4. 2.4 Viral Vector Purification Media Industry Restraints
3 Viral Vector Purification Media Market by Company
  1. 3.1 Global Viral Vector Purification Media Company Revenue Ranking in 2025
  2. 3.2 Global Viral Vector Purification Media Revenue by Company (2021-2026)
  3. 3.3 Global Viral Vector Purification Media Sales Volume by Company (2021-2026)
  4. 3.4 Global Viral Vector Purification Media Average Price by Company (2021-2026)
  5. 3.5 Global Viral Vector Purification Media Company Ranking (2024-2026)
  6. 3.6 Global Viral Vector Purification Media Company Manufacturing Base and Headquarters
  7. 3.7 Global Viral Vector Purification Media Company Product Type and Application
  8. 3.8 Global Viral Vector Purification Media Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Viral Vector Purification Media Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Viral Vector Purification Media Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Viral Vector Purification Media Market by Type
  1. 4.1 Viral Vector Purification Media Type Introduction
  2. 4.1.1 AAV Affinity Media
  3. 4.1.2 Anion Exchange Media
  4. 4.1.3 Cation Exchange Media
  5. 4.1.4 Mixed-Mode Media
  6. 4.1.5 Core-Bead Flow-Through Media
  7. 4.1.6 Monolith and Membrane Adsorbers
  8. 4.2 Global Viral Vector Purification Media Sales Volume by Type
  9. 4.2.1 Global Viral Vector Purification Media Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Viral Vector Purification Media Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Viral Vector Purification Media Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Viral Vector Purification Media Sales Value by Type
  13. 4.3.1 Global Viral Vector Purification Media Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Viral Vector Purification Media Sales Value by Type (2021-2032)
  15. 4.3.3 Global Viral Vector Purification Media Sales Value Share by Type (2021-2032)
5 Viral Vector Purification Media Market by Application
  1. 5.1 Viral Vector Purification Media Application Introduction
  2. 5.1.1 AAV Gene Therapy Vector Production
  3. 5.1.2 Lentiviral Vector Production
  4. 5.1.3 Adenoviral Vector and Vaccine Production
  5. 5.1.4 Oncolytic Virus and VLP Production
  6. 5.1.5 Process Development and Scale-Up
  7. 5.1.6 QC and Analytical Sample Preparation
  8. 5.2 Global Viral Vector Purification Media Sales Volume by Application
  9. 5.2.1 Global Viral Vector Purification Media Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Viral Vector Purification Media Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Viral Vector Purification Media Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Viral Vector Purification Media Sales Value by Application
  13. 5.3.1 Global Viral Vector Purification Media Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Viral Vector Purification Media Sales Value by Application (2021-2032)
  15. 5.3.3 Global Viral Vector Purification Media Sales Value Share by Application (2021-2032)
6 Viral Vector Purification Media Regional Sales and Value Analysis
  1. 6.1 Global Viral Vector Purification Media Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Viral Vector Purification Media Sales by Region (2021-2032)
  3. 6.2.1 Global Viral Vector Purification Media Sales by Region: 2021-2026
  4. 6.2.2 Global Viral Vector Purification Media Sales by Region (2027-2032)
  5. 6.3 Global Viral Vector Purification Media Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Viral Vector Purification Media Sales Value by Region (2021-2032)
  7. 6.4.1 Global Viral Vector Purification Media Sales Value by Region: 2021-2026
  8. 6.4.2 Global Viral Vector Purification Media Sales Value by Region (2027-2032)
  9. 6.5 Global Viral Vector Purification Media Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Viral Vector Purification Media Sales Value (2021-2032)
  12. 6.6.2 North America Viral Vector Purification Media Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Viral Vector Purification Media Sales Value (2021-2032)
  15. 6.7.2 Europe Viral Vector Purification Media Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Viral Vector Purification Media Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Viral Vector Purification Media Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Viral Vector Purification Media Sales Value (2021-2032)
  21. 6.9.2 South America Viral Vector Purification Media Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Viral Vector Purification Media Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Viral Vector Purification Media Sales Value Share by Country, 2025 VS 2032
7 Viral Vector Purification Media Country-level Sales and Value Analysis
  1. 7.1 Global Viral Vector Purification Media Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Viral Vector Purification Media Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Viral Vector Purification Media Sales by Country (2021-2032)
  4. 7.3.1 Global Viral Vector Purification Media Sales by Country (2021-2026)
  5. 7.3.2 Global Viral Vector Purification Media Sales by Country (2027-2032)
  6. 7.4 Global Viral Vector Purification Media Sales Value by Country (2021-2032)
  7. 7.4.1 Global Viral Vector Purification Media Sales Value by Country (2021-2026)
  8. 7.4.2 Global Viral Vector Purification Media Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Viral Vector Purification Media Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Viral Vector Purification Media Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Viral Vector Purification Media Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cytiva
  2. 8.1.1 Cytiva Company Information
  3. 8.1.2 Cytiva Business Overview
  4. 8.1.3 Cytiva Viral Vector Purification Media Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Cytiva Viral Vector Purification Media Product Portfolio
  6. 8.1.5 Cytiva Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Viral Vector Purification Media Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Viral Vector Purification Media Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 Repligen
  14. 8.3.1 Repligen Company Information
  15. 8.3.2 Repligen Business Overview
  16. 8.3.3 Repligen Viral Vector Purification Media Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Repligen Viral Vector Purification Media Product Portfolio
  18. 8.3.5 Repligen Recent Developments
  19. 8.4 Sartorius
  20. 8.4.1 Sartorius Company Information
  21. 8.4.2 Sartorius Business Overview
  22. 8.4.3 Sartorius Viral Vector Purification Media Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sartorius Viral Vector Purification Media Product Portfolio
  24. 8.4.5 Sartorius Recent Developments
  25. 8.5 Bio-Rad
  26. 8.5.1 Bio-Rad Company Information
  27. 8.5.2 Bio-Rad Business Overview
  28. 8.5.3 Bio-Rad Viral Vector Purification Media Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Bio-Rad Viral Vector Purification Media Product Portfolio
  30. 8.5.5 Bio-Rad Recent Developments
  31. 8.6 Merck
  32. 8.6.1 Merck Company Information
  33. 8.6.2 Merck Business Overview
  34. 8.6.3 Merck Viral Vector Purification Media Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Merck Viral Vector Purification Media Product Portfolio
  36. 8.6.5 Merck Recent Developments
  37. 8.7 Tosoh Bioscience
  38. 8.7.1 Tosoh Bioscience Company Information
  39. 8.7.2 Tosoh Bioscience Business Overview
  40. 8.7.3 Tosoh Bioscience Viral Vector Purification Media Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Tosoh Bioscience Viral Vector Purification Media Product Portfolio
  42. 8.7.5 Tosoh Bioscience Recent Developments
  43. 8.8 Astrea Bioseparations
  44. 8.8.1 Astrea Bioseparations Company Information
  45. 8.8.2 Astrea Bioseparations Business Overview
  46. 8.8.3 Astrea Bioseparations Viral Vector Purification Media Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Astrea Bioseparations Viral Vector Purification Media Product Portfolio
  48. 8.8.5 Astrea Bioseparations Recent Developments
  49. 8.9 JNC
  50. 8.9.1 JNC Company Information
  51. 8.9.2 JNC Business Overview
  52. 8.9.3 JNC Viral Vector Purification Media Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 JNC Viral Vector Purification Media Product Portfolio
  54. 8.9.5 JNC Recent Developments
  55. 8.10 Sepax Technologies
  56. 8.10.1 Sepax Technologies Company Information
  57. 8.10.2 Sepax Technologies Business Overview
  58. 8.10.3 Sepax Technologies Viral Vector Purification Media Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sepax Technologies Viral Vector Purification Media Product Portfolio
  60. 8.10.5 Sepax Technologies Recent Developments
  61. 8.11 Sunresin
  62. 8.11.1 Sunresin Company Information
  63. 8.11.2 Sunresin Business Overview
  64. 8.11.3 Sunresin Viral Vector Purification Media Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sunresin Viral Vector Purification Media Product Portfolio
  66. 8.11.5 Sunresin Recent Developments
  67. 8.12 Bestchrom
  68. 8.12.1 Bestchrom Company Information
  69. 8.12.2 Bestchrom Business Overview
  70. 8.12.3 Bestchrom Viral Vector Purification Media Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Bestchrom Viral Vector Purification Media Product Portfolio
  72. 8.12.5 Bestchrom Recent Developments
  73. 8.13 NanoMicro
  74. 8.13.1 NanoMicro Company Information
  75. 8.13.2 NanoMicro Business Overview
  76. 8.13.3 NanoMicro Viral Vector Purification Media Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 NanoMicro Viral Vector Purification Media Product Portfolio
  78. 8.13.5 NanoMicro Recent Developments
  79. 8.14 BioToolomics
  80. 8.14.1 BioToolomics Company Information
  81. 8.14.2 BioToolomics Business Overview
  82. 8.14.3 BioToolomics Viral Vector Purification Media Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 BioToolomics Viral Vector Purification Media Product Portfolio
  84. 8.14.5 BioToolomics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Viral Vector Purification Media Value Chain Analysis
  2. 9.1.1 Viral Vector Purification Media Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Viral Vector Purification Media Sales Mode & Process
  6. 9.2 Viral Vector Purification Media Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Viral Vector Purification Media Distributors
  9. 9.2.3 Viral Vector Purification Media Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst